We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Attorney Mistake Dooms Angiomax Patent Extension

Law360 (December 11, 2006, 12:00 AM EST) -- The Medicines Co. disclosed Monday that the U.S. Patent and Trademark Office has rejected its application to extend its patent on the blood thinning drug Angiomax.

In papers filed with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.